Scor (OTCMKTS:SCRYY) Shares Up 5.1% – Should You Buy?

Scor SE (OTCMKTS:SCRYY – Get Free Report)’s stock price was up 5.1% during trading on Friday. The company traded as high as $4.15 and last traded at $4.15. 211 shares changed hands during trading, a decline of 97% from the average daily volume of 7,859 shares. The stock had previously closed at $3.95.

Analysts Set New Price Targets

Separately, UBS Group downgraded shares of Scor from a “hold” rating to a “sell” rating in a research report on Tuesday, August 18th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Read Our Latest Analysis on SCRYY

Scor Price Performance

The business’s 50 day moving average price is $3.83 and its 200 day moving average price is $3.72. The stock has a market capitalization of $7.44 billion, a P/E ratio of 7.83 and a beta of 0.50.

Scor (OTCMKTS:SCRYY – Get Free Report) last issued its quarterly earnings data on Friday, October 30th. The financial services provider reported $0.13 EPS for the quarter, topping the consensus estimate of $0.12 by $0.01. Scor had a return on equity of 18.99% and a net margin of 5.41%. The company had revenue of $4.21 billion during the quarter, compared to analyst estimates of $4.19 billion. As a group, analysts forecast that Scor SE will post 0.47 earnings per share for the current fiscal year.

About Scor

(Get Free Report)

SCOR SE is a global reinsurer headquartered in Paris, France. It provides reinsurance and risk-management solutions to insurance companies, helping them manage and transfer risks associated with events such as natural disasters, accidents, illness and longer-term changes in mortality and longevity. The company’s main activities span Property & Casualty reinsurance and Life & Health reinsurance. Its offerings include coverage for property and casualty risks, as well as solutions related to life insurance, health and longevity.

Featured Articles

Receive News & Ratings for Scor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scor and related companies with MarketBeat.com's FREE daily email newsletter.